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• Identify challenges to the forensic pathology 
profession as a whole and at FPA
• Propose solutions to improve recruitment and 










































• Increasing caseloads, lack of physicians entering 
profession
– Only 30 to 40 physicians enter forensic pathology each year1
– One of the lowest paid physician specialties
– A large proportion of working FPs are nearing retirement age 
with no replacements
– Many FPs are overwhelmed with cases and are more likely 
to suffer from physician burnout
– There were an estimated 500 FPs working in the United 
States in 2012, however it is projected that at least 1000 are 
needed to cover the country1
• Use of FPA annual reports to track case 
statistics
• Research of forensic pathology and opioid 
epidemic sources (see references)
• Subject matter experts  
• Role of Forensic Pathologists 
– To establish the cause of death of a decedent by means 
of an autopsy
– Give a medical opinion as to the manner of death
• Natural, Homicide, Accident, etc
• Forensic Pathology Associates 
– Established in 1993 as a private organization
– Incorporated by Health Network Laboratories in 2010
– Currently employs four forensic pathologists as well as 
four forensic pathology assistants
– Services 30 counties and hospitals in eastern and 
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• Opioid Epidemic 
– Some models predict the opioid epidemic will not 
stabilize until 20252
– Some FP offices have resorted to only performing 
toxicology testing and/or external examinations on 
apparent drug deaths   
• NAME Accreditation Standards 
– National Association of Medical Examiners accredits 
offices and systems for high standards of death 
investigation 
– Prohibits FPs of accredited offices from performing more 
than 325 autopsies
• Looking Ahead
– HNL must be able to attract the few FPs available to 
continue FPA’s high standards of quality, maintain NAME 
accreditation, and avoid physician burnout
• Recruitment and Retention
– Competitive salary and signing bonuses
– Federal Student Loan Forgiveness 
• Currently unavailable for (for-profit) HNL FPs
• Solution: allow FPs to be employees of (not-for-
profit) Lehigh Valley Health Network and have 
them contracted to FPA   
– Short term sabbaticals
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